N2B (Nose-to-Brain) delivery of anti-TB drugs using particulate drug delivery system to ameliorate Tuberculous Meningitis (TBM) & enhance functional recovery | India Science, Technology & Innovation - ISTI Portal

×

Acces sibility Controls

N2B (Nose-to-Brain) delivery of anti-TB drugs using particulate drug delivery system to ameliorate Tuberculous Meningitis (TBM) & enhance functional recovery

Implementing Organization

Principal Investigator

Dr. A.K. Singh Scientist C ICMR-National Jalma Institute for Leprosy & other Mycobacterial Diseases Tajganj Uttar Pradesh

Related Research

Quick Information

Area of Research

Medical Sciences

Focus Area

Medical Research

Start Year

2020

End Year

2021

Duration

36

Sanction Amount

₹ 8.22 L

Status

Completed

Output

No. of Research Paper

00

Technologies (If Any)

00

No. of PhD Produced

00

No. of Patents

Filed : 00

Grant : 00

Disclaimer: Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.

Latest Updates

Loading…